Saturday, October 5, 2013

APPEARING TO BE INVESTMENTS VIA RUSSIA, RECYCLING THE PETRO$US? AND THE KILLING MACHINES SUCH AS THE FDA ET AL, ET CETERA

 

The government knows it’s a medical killing machine
Jon Rappoport, October 5, 2013, www.nomorefakenews.com

Here are four smoking guns that substantiate the title of this article.  Smoking gun #1: As I detailed in my two previous articles (click here and here), Dr. Barbara Starfield’s article in the July 26, 2000, Journal of the American Medical Association, “Is US Health Really the Best in the World?”, spelled out the damage:

NO BOUNDARIES MEANS NO HUMAN IS SAFE IN THE BOUNDARY-LESSNESS


The US medical system kills 225,000 Americans per year. That’s well over two MILLION deaths per decade.
 
The US government supports, in numerous ways, this system. And now, through the implementation of Obamacare, many more previously uninsured Americans will enter the killing fields.

Dr. Starfield’s data are not classified. They’re not a state secret. Any doctor or medical bureaucrat has access to them.

Yet nothing of note is being done to remedy the ongoing crime.

Smoking gun #2: Starfield’s report indicated that, every year in the US, 106,000 Americans die as a result of FDA-approved medical drugs.

The FDA is the only agency tasked with certifying these drugs as safe and effective. With such certification, the drugs enter the public pipeline.

On the FDA’s own website, under the heading, “Why Learn About Adverse Drug Reactions,” appears the following text: “Over 2 MILLION ADRs [Adverse Drug Reactions] yearly; 100,000 DEATHS yearly; ADRs 4th leading cause of death…”

Astonishingly, the FDA takes no responsibility for any of this. They, and only they, can approve the drugs as safe and effective. They list the numbers of deaths and maimings, and they never admit culpability.

Smoking gun #3: It’s common knowledge that there is a revolving door between the FDA and drug companies. Employees come and go from one organization/agency to another. The FDA and the pharmaceutical industry are, in significant respects, partners.

For years, there were reports of payoffs and pressure, at the FDA, to grant approval to drugs that were, in fact, harmful and dangerous.

Then, in 2009 and again in July 2012, a scandal erupted. As Truthout reported, it focused on “an institutionalized FDA spying program on its own scientists, law makers, reporters and academics that included an enemies list…”
At the heart of the scandal: FDA pressure on its own people to approve medical devices that were dangerous.
Truthout took a further step. It interviewed Ronald Cavanagh, a former drug reviewer for the FDA. (July 29, 2012, “Former FDA Reviewer Speaks Out About Intimidation and Marginalizing of Safety”)

In a stunning interview with Truthout’s Martha Rosenberg, Cavanagh, exposed the FDA as a relentless criminal mafia protecting its client, Big Pharma, with a host of mob strategies.

Cavanagh: “…widespread racketeering, including witness tampering and witness retaliation.”
I was threatened with prison.”

One [FDA] manager threatened my children…I was afraid that I could be killed for talking to Congress and criminal investigators.”

Cavanagh reviewed new drug applications made to the FDA by pharmaceutical companies. He was one of the holdouts at the Agency, who insisted that the drugs had to be safe and effective before being released to the public. That’s why he was under the gun.

Honest appraisal wasn’t part of the FDA culture, and Cavanagh swam against the tide, until he realized his life and the life of his children might be on the line.

What was his secret and unofficial task at the FDA supposed to be? “Drug reviewers were clearly told not to question drug companies and that our job was to approve drugs.” In other words, rubber stamp them. Say the drugs were safe and effective when they were not.

Cavanagh’s revelations are astonishing. He recalls a meeting where a drug-company representative flat-out stated that his company had paid the FDA for a new-drug approval. Paid for it. As in bribe.

Cavanagh remarks that the drug pyridostigmine, given to US troops to prevent the later effects of nerve gas, “actually increased the lethality” of certain nerve agents.

Cavanagh recalls being given records of safety data on a drug that was up for approval—and then his bosses told him which sections not to read. Obviously, they knew the drug was dangerous and they knew exactly where, in the reports, that fact would be revealed.

The FDA is an ongoing criminal enterprise, and any government official, serving in any capacity, who has become aware of it and has not taken action, is an accessory to mass poisoning of the population.

Smoking gun #4: Before the FDA considers approving a new drug, studies and clinical trials have to be done. The drug companies do those clinical trials and submit the results to the FDA.

Obviously, the results look good; otherwise the FDA wouldn’t be able to certify the drugs as safe and effective.

This raises the specter of research fraud—because, since the drugs kill 106,000 Americans every year, how can published studies praising these drugs be authentic and credible?

On January 15, 2009, the NY Review of Books published a devastating quote from a woman who, for 20 years, edited the most prestigious medical journal in the world: 

It is simply no longer possible to believe much of the clinical research that is published, or to rely on the judgment of trusted physicians or authoritative medical guidelines. I take no pleasure in this conclusion, which I reached slowly and reluctantly over my two decades as an editor of The New England Journal of Medicine.”
(Marcia Angell, MD, “Drug Companies and Doctors: A story of Corruption.” NY Review of Books, Jan. 15, 2009.)

Here is another quote of a similar nature, also published in the NY Review of Books (May 12, 2001, Helen Epstein, “Flu Warning: Beware of Drug Companies”):

Six years ago, John Ioannidis, a professor of epidemiology at the University of Ioannina School of Medicine in Greece, found that nearly half of published articles in scientific journals contained findings that were false.”

Here’s another quote from the same >>“Last year, GlaxoSmithKline’s diabetes drug Avandia was linked to thousands of heart attacks, and earlier in the decade, the company’s antidepressant Paxil was discovered to exacerbate the risk of suicide in young people. Merck’s painkiller Vioxx was also linked to thousands of heart disease deaths. In each case, the scientific literature gave little hint of these dangers.” 

And finally, here is yet another statement from Marcia Angell, former editor of The New England Journal of Medicine: 

A review of seventy-four clinical trials of antidepressants, for example, found that thirty-seven of thirty-eight positive studies [that praised the drugs] were published. But of the thirty-six negative studies, thirty-three were either not published or published in a form that conveyed a positive outcome.”

It turns out that the informational pipeline that feeds the entire perception of pharmaceutical medicine is a rank fraud.

Could any major newspaper add up these quotes and launch an all-out attack on the massive crimes surrounding medical studies? Of course. And that attack, if carried out long enough, would shake the pillars of the Church of Modern Medicine. But it doesn’t happen.

Neither do we see extensive Congressional hearings on the horrendous effects of the US medical system. The Dept. of Justice does nothing, when they should be making mass arrests and laying on criminal prosecutions.
They know the scope of the medical killings and maimings. They choose to do nothing.

And now, into the maw of this dragon of death, will step millions of previously uninsured Americans, glad recipients of Obamacare.

Jon Rappoport, The author of two explosive collections, THE MATRIX REVEALED and EXIT FROM THE MATRIX, Jon was a candidate for a US Congressional seat in the 29th District of California. Nominated for a Pulitzer Prize, he has worked as an investigative reporter for 30 years, writing articles on politics, medicine, and health for CBS Healthwatch, LA Weekly, Spin Magazine, Stern, and other newspapers and magazines in the US and Europe. Jon has delivered lectures and seminars on global politics, health, logic, and creative power to audiences around the world. You can sign up for his free emails at www.nomorefakenews.com

[SIDEBAR:  IN NOVEMBER 2012, LAS VEGAS, NEVADA, A TRIAL AGAINST THE FDA FOUND IN DECEMBER AFTER AN APPEAL WAS FILED FOR A NEW TRIAL, DUE TO THE CORRUPTION OF THE JURY TAMPERING AND THE JUDGE, DR. RALPH CONTI DEAD!

OH MY GOD, KENT DAWSON AND HIS WAR RACKET THUGS CRANE POMERANTZ WHO THE LAWYER DENNIS ROBERTS SAID HIS 'GAYDAR' PICKED UPON ON THIS FREAK OF NATURE .... INVESTIGATIONS INTO SHELDON ADELSON'S NEVADA WHERE THE MEDICAL INDUSTRIAL COMPLEX WOULD HAVE NO JEWRY POLITICAL COMPETITION FROM THE GOYIM, ET AL.

GRADUATING FROM UTAH LAW, AND APPOINTED VIA CLINTON WHILE THE RAT MOFO WAS "UNDER A CLOUD."

WHERE DO THE FINE SPECIMENS ARRIVE TO THE JUDICIAL FROM?
HE GAVE A FAMOUS LAWYER, DENNIS ROBERTS, A TWINKIE FOR HIS BIRTHDAY AND WHAT DID THE OTHER LAWYER GET FROM THE DINNER AT INFAMOUS OSCAR'S ... A WEEK DOWN IN THE BED, NO ONE UNDERSTOOD WHAT HAD HAPPENED AT THAT DINNER, OTHER THAN A 'WAITER' WHO LOOKED LIKE THE CIA-FBI-MOSSAD, GAVE THE COUNSEL THAT WAS IN CHARGE OF THE CASE SOME WATER MIXED WITH SOME WINE AND THE LUCKY TRICK WAS, THE LAWYER ONLY DRANK A SMALL AMOUNT AFTER FIGHTING WITH THE CIA TO NOT POUR ANYMORE OF THE 'CONTROLLED SUBSTANCE' FROM THE 'RESTAURANT'

Reid selects Las Vegas lawyer for U.S. District Court

Senate Majority Leader Harry Reid has recommended a young Las Vegas lawyer as a replacement for U.S. District Judge Philip Pro, who is taking "senior status" at the end of the year.

Reid, D-Nev., said he sent Ariel Stern's name last week to President Barack Obama. Reid made the revelation Friday during a visit to the Las Vegas Review-Journal.

"His father was a Cuban Jew," Reid said. "He was born in Mexico, speaks fluent Spanish. He's just a brilliant man."

http://www.reviewjournal.com/news/crime-courts/reid-selects-las-vegas-lawyer-us-district-court


DR. RALPH CONTI WAS FOUND DEAD IN THE HOSPITAL AND NO EXAMINATION CAN SAY 'WHY'.  NOW WHAT HAPPENED TO DR. CONTI IS HOW THE FDA CONDUCTS THE NEW WORLD ORDER.  DR. CONTI RESEARCHED STEM CELLS AND THE FDA DIDN'T WANT STEM CELL RESEARCH BECAUSE THE DRUG INDUSTRY WAS TO BE THE CALLERS OF WHATEVER HAPPENS IN THE USA.  DR. CONTI BELIEVED IN THE TOXICOLOGY TOO, NOT THAT HE DIDN'T SUPPORT THE FDA BIG PHARMA.  NO, HE WANTED TO FIND A CURE FOR THE POOR HUMANS -- THAT HAVE BEEN COMPROMISED VIA VACCINATIONS OR, NAME A POISON THE USAGOV DOESN'T USE (THAT IS THE ROTS-CHILD'S IS-RA HELL'S OCCUPATION OF US), TO ABUSE THE NATURAL LAW OF ORGANIC FORM IN THE MYSTICAL AND THIS IS WHAT DRIVES THE CRIMINALLY INSANE FURTHER INTO THE PIT OF NO RETURN FOR THE BRAIN DEAD.]

http://theartof12.blogspot.com/2013/10/russia-united-stasi-states-is-ra-hells.html 

More than 30 global corporations including Boeing, Cisco Systems, General Electric, Samsung, and Johnson & Johnson have signed research and development partnership deals with Skolkovo, and 28 of those — more than half American — have pledged to invest a combined $500 million.

“Skolkovo is a massive government-led effort to diversify the Russian economy away from its dependency on natural resources,” Vekselberg said in an emailed statement. “Skolkovo’s American partners play a vital role in this effort.”

The $500 million will be used in part “to establish corporate research and development centers at Skolkovo,” Vekselberg said.


Skoltech aims to have 300 full-time faculty by 2020, Vekselberg said.

U.S.-Russian Operations

Capital commitments from Rusnano have been paired with agreements by the target companies to establish manufacturing or research operations in Russia, Akhanov said. Joint ventures set up by Rusnano and its partners have commissioned 30 research and production facilities across Russia.

Thanks to these and other measures, nine out of 24 drugs approved by the U.S. Federal Drug Administration in the third quarter were clinically tested in Russia.

Rusnano is led by Anatoly Chubais, the redheaded former Deputy Prime Minister who played a key role in privatizing Soviet industries back in the 1990s. The company, whose name derives from its mandate to invest in nanotechnology, was set up in 2007 by an act of parliament and converted into a joint-stock company in 2011.

Rusnano’s web site says the company aims to boost nanotech business activity in Russia up to an annual sector-wide turnover of $30 billion by 2015.

Rusnano has teamed up with Princeton, New Jersey-based Domain Associates LLC, a healthcare-focused venture capital firm that has raised over $2.7 billion, according to the firm’s web site. The two firms have targeted a combined co-investment of about $760 million into approximately 20 U.S.-based healthcare companies.

In July, Rusnano, Domain Associates and other investors injected $55 million into ReVision Optics, Inc., a California-based firm which is researching solutions for age-related eyesight deterioration.

Research Partnership

Rusnano invested $52 million into two Boston-area biopharmaceutical research companies, BIND Biosciences and Selecta Biosciences, with additional funds from private investors. As part of the deal, BIND and Selecta established subsidiaries in Russia to research technology and run clinical trials.

Selecta is researching a vaccine against nicotine addiction. BIND is developing therapeutic nanoparticles that target cancerous tumors.

Dixon Doll, co-founder and partner of the Menlo Park, California-based venture capital firm DCM, said in an interview that government action can indeed help spur venture activity. But he said the state’s most important role should be creating space for private capital to flourish.

“The government can be very helpful in stimulating a vibrant entrepreneurial ecosystem,” Doll says. “If Russia wants a good model, it should look long and hard at what China did,” he said, pointing to a series of Chinese laws allowing foreign investors to put money into offshore vehicles that could easily and securely invest in Chinese startups.

Rusnano, RVC and Skolkovo hosted the second annual Russian Innovation Week conference in Boston on Sept. 17 and in Silicon Valley on Sep. 19-20, attended by Chubais, Vekselberg and Agamirzian.

“Judging from the first day of the conference, there seems to be a lot of enthusiasm for Russian ideas from American business,” said Rinat Dosmukhamedov, Russian Trade Representative in the U.S. "Russia demonstrated not only world-class scientific developments, inlcuding in biosciences and IT, but also a preparedness to promote them on the American market."

“We need American expertise even more than investments,” Vekselberg said. “We have big plans, and working together with American partners, we can make these a reality.”
 


1 comment:

  1. GLOBAL GENOCIDE TAKES A LOT OF CARE AND OBAMA WAS IS THE 'MAN' FOR THE OCCASION WITH LOTS OF HELP FROM THE CRIMINALLY INSANE THAT HAVE BEEN SLOBS AND A BLOB TO GET THE JOB WELL DONE

    ReplyDelete